Skip to main content

REVIEW article

Front. Immunol.

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1570698

This article is part of the Research Topic Oncolytic Viruses in Cancer Treatment: Exploring Molecular Mechanisms View all 3 articles

Oncolytic Viruses: A Promising Therapy for Malignant Pleural Effusion and Solid Tumors

Provisionally accepted
  • Hubei University of Technology, Wuhan, China

The final, formatted version of the article will be published soon.

    Oncolytic viruses (OVs) are natural or recombinant viruses that can directly lyse tumor cells without damaging normal cells. They enhance anti-tumor immunity by releasing antigens and activating inflammatory responses within the tumor microenvironment (TME). This offers a new therapeutic approach for MPE and solid tumors. This review discusses the progress of OVs administered via intrapleural and intratumoral routes, emphasizing their potential in MPE treatment and the challenges posed by the complex intrapleural environment, which affects the direct interaction between OVs, tumor cells, and immune cells. This review also discusses the regulatory barriers, safety concerns and accessibility of Oncolytic virus therapy.

    Keywords: oncolytic virus, malignant pleural effusion, Tumor Microenvironment, Solid tumor, Intracavitary administration

    Received: 04 Feb 2025; Accepted: 31 Mar 2025.

    Copyright: © 2025 Wang, Zhou, Zhang, Hu, Liu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yang Wang, Hubei University of Technology, Wuhan, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more